Search
Searching Goglides
Loading matching companies, research, topics, and discussions.
Loading matching companies, research, topics, and discussions.
Search uses Goglides API results from the projection-backed discovery index. Private, draft, hidden, unpublished, and admin-only content stays out of public results.
Showing public results only.
AEON is trying to turn ABP-450 into a U.S. therapeutic BOTOX biosimilar, but the current setup combines FDA-pathway optionality with no commercial revenue, going-concern language, a short runway, listing pressure and heavy Daewoong concentration.
Signed-in searches appear here after you use search.
Tag facets appear after tag usage counts are rebuilt.
Anfield Energy's updated PEA makes the Shootaring mill restart look explosive, but AEC is still a no-revenue uranium developer that has to clear permits, capital, reserves, construction, and first production.
OpenAchieve has late-stage cytisinicline data, an accepted smoking-cessation NDA, and a fresh financing. The catch is that management now expects a manufacturing-driven FDA Complete Response Letter before any U.S. launch.
OpenOfficial-source baseline for ABAT using SEC submissions, SEC XBRL companyfacts, FY2025 10-K, Q3 FY2026 10-Q, filed Q3 results exhibit, Tonopah technical materials, proxy materials, ATM filings, and official peer filings.
OpenTag facets appear after tag usage counts are rebuilt.